Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 76.10M | 66.86M | 59.37M | 50.27M | 43.13M | 43.52M |
Gross Profit | 33.12M | 27.48M | 25.69M | 19.06M | 16.97M | 19.36M |
EBITDA | -16.91M | -3.98M | ― | -5.20M | 5.90M | -66.50K |
Net Income | -20.48M | -7.23M | -9.20M | -13.29M | 393.78K | -8.89M |
Balance Sheet | ||||||
Total Assets | 46.96M | 44.12M | 48.45M | 45.76M | 52.94M | 63.79M |
Cash, Cash Equivalents and Short-Term Investments | 7.05M | 3.91M | 5.34M | 9.91M | 15.44M | 20.38M |
Total Debt | 22.56M | 23.12M | 26.75M | 21.84M | 9.26M | 15.17M |
Total Liabilities | 43.11M | 39.15M | 40.11M | 31.12M | 29.39M | 31.84M |
Stockholders Equity | 3.62M | 4.71M | 7.69M | 13.94M | 22.59M | 30.87M |
Cash Flow | ||||||
Free Cash Flow | -765.86K | -5.25M | -4.99M | -17.94M | -11.12M | -5.66M |
Operating Cash Flow | 1.54M | -3.95M | -2.23M | -16.09M | -10.05M | -4.09M |
Investing Cash Flow | -2.33M | -1.26M | -5.63M | 6.61M | 840.90K | 764.55K |
Financing Cash Flow | 1.65M | 4.40M | 2.04M | 5.02M | 4.45M | 24.07M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
61 Neutral | $36.05B | 6.66 | -10.10% | 1.86% | 8.68% | -8.81% | |
56 Neutral | $3.01M | 0.44 | -12.71% | ― | -5.08% | 93.27% | |
52 Neutral | $7.15M | <0.01 | -1102.76% | ― | 16.50% | ― | |
46 Neutral | $8.15M | ― | -349.71% | ― | 30.52% | 56.70% | |
39 Underperform | $9.88M | ― | -2201.06% | ― | -33.86% | 74.09% | |
34 Underperform | $2.91M | ― | 470.97% | ― | ― | ― | |
― | $31.15M | ― | -269.39% | ― | ― | ― |
Cemtrex, Inc. faced a compliance issue with Nasdaq’s minimum stockholder’s equity requirement, which mandates a minimum equity of $2.5 million. On February 21, 2025, the company was notified of its non-compliance due to its equity falling below this threshold. However, by June 4, 2025, Cemtrex had successfully regained compliance, reporting a stockholder’s equity of $6,403,022, thus resolving the issue.
Soluna Holdings, Inc. entered into an underwriting agreement with Aegis Capital Corp. to sell 1,250,000 shares of its common stock at $1.00 per share in a public offering. On June 3, 2025, the company closed the offering, including an over-allotment option, resulting in gross proceeds of approximately $187,500.
On May 28, 2025, Cemtrex, Inc. entered into an underwriting agreement with Aegis Capital Corp. to sell 1,250,000 shares of its common stock at $1.00 per share, expecting to raise approximately $1.25 million in gross proceeds. The offering, which closed on May 29, 2025, is intended to support general corporate purposes, debt reduction, and working capital, potentially impacting Cemtrex’s financial flexibility and market positioning.